Europe Medical Cannabis Market - Industry Trends and Forecast to 2030

List of Tables

Europe medical cannabis market is expected to reach USD 24,646.06 million by 2031 from USD 2,625.67 million in 2023, growing at a CAGR of 33.6% during the forecast period of 2023 to 2030

Market Segmentation:

Europe Medical Cannabis Market, By Product (Oil, Dried Medial Cannabis, Medical Cannabis Capsules, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, and Others), Source (Synthetic and Natural), Species (Cannabis Indica, Sativa, and Hybrid ), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), (Application (Pain Management, Anxiety, Muscle Spasms, Nausea, Appetite Loss, Cancer, Arthritis, Alzheimer's Disease/Migranes, Epilepsy, Depression And Sleep Disorders, Multiple Sclerosis, Autism, Mental Health Conditions, Elevate Mood, and Others), Route of Administration (Oral Solutions And Capsules, Smoking, Vaporizers, Topicals, and Others) (End User (Pharmaceutical Industry, Research and Development Centers, Homecare Settings, Hospital And Rehab Centers, and Others), Distribution Channel (B2B and B2C), Country (Germany, U.K., Ital, Netherlands, Switzerland, France, Russia, Spain, Belgium, Greece, Luxembourg, and Rest of Europe) Industry Trends & Forecast To 2031.

Overview of Europe Medical Cannabis Market Dynamics

Driver
Rise in incidence of diseases that require the use of cannabis
Restraint
Ethical issues related to the use of medical cannabis
Opportunity
Increased medicinal use of medical cannabis

Market Players

Some of the major players operating in the Europe medical cannabis market are:

Tilray
Medipharm Labs
Althea Company Pty Ltd
PharmaHemp
Aurora Cannabis
CANOPY GROWTH CORPORATION
Jazz Pharmaceuticals, Inc.
ECOGEN BIOSCIENCES
GRASS & CO.,
CANNARAY
Sanity Group GmbH.
HEXO Corp.

1 INTRODUCTION 31

1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.3 OVERVIEW OF THE EUROPE MEDICAL CANNABIS MARKET 31
1.4 LIMITATIONS 33
1.5 MARKETS COVERED 34

2 MARKET SEGMENTATION 38

2.1 MARKETS COVERED 38
2.2 GEOGRAPHICAL SCOPE 39
2.3 YEARS CONSIDERED FOR THE STUDY 39
2.4 CURRENCY AND PRICING 39
2.5 DBMR TRIPOD DATA VALIDATION MODEL 40
2.6 MULTIVARIATE MODELLING 43
2.7 PRODUCT LIFELINE CURVE 43
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 44
2.9 DBMR MARKET POSITION GRID 45
2.10 MARKET END USER COVERAGE GRID 46
2.11 VENDOR SHARE ANALYSIS 47
2.12 SECONDARY SOURCES 48
2.13 ASSUMPTIONS 48

3 EXECUTIVE SUMMARY 49

4 PREMIUM INSIGHTS 52

4.1 PORTER'S FIVE FORCES 53
4.2 PESTEL ANALYSIS 54
4.3 EUROPE MEDICAL CANNABIS MARKET: AVAILABLE PRODUCTS WITH PRICES 55

5 EUROPE MEDICAL CANNABIS MARKET: REGULATIONS 57

6 MARKET OVERVIEW 63

6.1 DRIVERS 65
- 6.1.1 RISE IN GERIATRIC POPULATION 65
- 6.1.2 RISE IN INCIDENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS 65
- 6.1.3 AUTHORITY OF CANNABIS FOR MEDICAL PURPOSES 66
- 6.1.4 INCREASED USAGE OF CANNABIS SEEDS IN COSMETIC PRODUCTS 67
- 6.1.5 FUNCTIONAL PROPERTIES OF CANNABIS AND THEIR INCREASED USE IN DIFFERENT INDUSTRIES 67
6.2 RESTRAINTS 68
- 6.2.1 LONG TERM AND SHORT TERM SIDE EFFECTS RELATED TO THE USE OF CANNABIS AND CANNABIS OVERUSE 68
- 6.2.2 HIGH COST ASSOCIATED WITH OBTAINING CANNABIS 69
- 6.2.3 ETHICAL ISSUES RELATED TO THE USE OF MEDICAL CANNABIS 69
- 6.2.4 COMPLEX REGULATORY STRUCTURE FOR USAGE OF CANNABIS 70
6.3 OPPORTUNITIES 71
- 6.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING RESEARCH AND DEVELOPMENT (R&D) ACTIVITIES 71
- 6.3.2 INCREASED MEDICINAL USE OF MEDICAL CANNABIS 71
- 6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 72
6.4 CHALLENGES 73
- 6.4.1 SHORTAGE OF SKILLED PROFESSIONAL IN THE INDUSTRY 73
- 6.4.2 RISE OF THE MARIJUANA BLACK MARKET 73

7 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT 74

7.1 OVERVIEW 75
7.2 OIL 77
7.3 DRIED MEDICAL CANNABIS 78
7.4 MEDICAL CANNABIS CAPSULES 78
7.5 VAPE PEN 79
7.6 WHOLE FLOWER 80
7.7 CREAMS & MOISTURIZER 80
7.8 GROUND FLOWER 80
7.9 OTHERS 80

8 EUROPE MEDICAL CANNABIS MARKET, BY SOURCE 81

8.1 OVERVIEW 82
8.2 NATURAL 83
8.3 SYNTHETIC 83

9 EUROPE MEDICAL CANNABIS MARKET, BY SPECIES 84

9.1 OVERVIEW 85
9.2 SATIVA 86
9.3 HYBRID 86
9.4 CANNABIS INDICA 86

10 EUROPE MEDICAL CANNABIS MARKET, BY DERIVATIVES 87

10.1 OVERVIEW 88
10.2 CANNABIDIOL (CBD) 89
10.3 (THC)/DELTA-8-TETRAHYDROCANNABINOL 89
10.4 OTHERS 89

11 EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION 90

11.1 OVERVIEW 91
11.2 PAIN MANAGEMENT 92
11.3 ANXIETY 93
11.4 MUSCLE SPASMS 94
11.5 NAUSEA 94
11.6 APPETITE LOSS 95
11.7 CANCER 95
11.8 ARTHRITIS 96
11.9 ALZHEIMER'S DISEASE/MIGRANES 96
11.10 EPILEPSY 97
11.11 DEPRESSION AND SLEEP DISORDERS 97
11.12 MULTIPLE SCLEROSIS 98
11.13 AUTISM 98
11.14 MENTAL HEALTH CONDITIONS 99
11.15 ELEVATE MODD 99
11.16 OTHERS 99

12 EUROPE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION 100

12.1 OVERVIEW 101
12.2 ORAL SOLUTION AND CAPSULES 102
12.3 SMOKING 102
12.4 TOPICALS 102
12.5 VAPORIZERS 102
12.6 OTHERS 102

13 EUROPE MEDICAL CANNABIS MARKET, BY END USER 103

13.1 OVERVIEW 104
13.2 HOMECARE SETTING 105
13.3 HOSPITAL 105
13.4 REHAB CENTERS 105
13.5 PHARMACEUTICAL INDUSTRY 105
13.6 RESEARCH AND DEVELOPMENT CENTERS 105
13.7 OTHERS 105

14 EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL 106

14.1 OVERVIEW 107
14.2 B2C 108
14.3 B2B 108

15 EUROPE MEDICAL CANNABIS MARKET, BY COUNTRY 109

15.1.1 GERMANY 112
15.1.2 U.K. 124
15.1.3 ITALY 136
15.1.4 NETHERLANDS 148
15.1.5 SWITZERLAND 160
15.1.6 FRANCE 172
15.1.7 RUSSIA 184
15.1.8 SPAIN 196
15.1.9 BELGIUM 208
15.1.10 GREECE 220
15.1.11 LUXEMBOURG 232
15.1.12 REST OF EUROPE 244

16 EUROPE MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE 245

16.1 COMPANY SHARE ANALYSIS: EUROPE 245

17 SWOT ANALYSIS 246

18 COMPANY PROFILES 247

18.1 JAZZ PHARMACEUTICALS PLC 247
- 18.1.1 COMPANY SNAPSHOT 247
- 18.1.2 REVENUE ANALYSIS 247
- 18.1.3 PRODUCT PORTFOLIO 248
- 18.1.4 RECENT DEVELOPMENT 248
18.2 TILRAY 249
- 18.2.1 COMPANY SNAPSHOT 249
- 18.2.2 REVENUE ANALYSIS 249
- 18.2.3 PRODUCT PORTFOLIO 250
- 18.2.4 RECENT DEVELOPMENTS 250
18.3 AURORA CANNABIS INC. (2021) 251
- 18.3.1 COMPANY SNAPSHOT 251
- 18.3.2 REVENUE ANALYSIS 251
- 18.3.3 PRODUCT PORTFOLIO 252
- 18.3.4 RECENT DEVELOPMENT 252
18.4 CANOPY GROWTH CORPORATION 253
- 18.4.1 COMPANY SNAPSHOT 253
- 18.4.2 REVENUE ANALYSIS 253
- 18.4.3 PRODUCT PORTFOLIO 254
- 18.4.4 RECENT DEVELOPMENTS 254
18.5 ECOGEN BIOSCIENCES 255
- 18.5.1 COMPANY SNAPSHOT 255
- 18.5.2 PRODUCT PORTFOLIO 255
- 18.5.3 RECENT DEVELOPMENTS 256
18.6 ALTHEA COMPANY PTY LTD (A SUBSIDIARY OF ALTHEA GROUP HOLDINGS LIMITED) 257
- 18.6.1 COMPANY SNAPSHOT 257
- 18.6.2 REVENUE ANALYSIS 257
- 18.6.3 PRODUCT PORTFOLIO 257
- 18.6.4 RECENT DEVELOPMENTS 258
18.7 CANNARAY 259
- 18.7.1 COMPANY SNAPSHOT 259
- 18.7.2 PRODUCT PORTFOLIO 259
- 1.5.1 RECENT DEVELOPMENT 259
18.8 GRASS & CO. 260
- 18.8.1 COMPANY SNAPSHOT 260
- 18.8.2 PRODUCT PORTFOLIO 260
- 18.8.3 RECENT DEVELOPMENT 260
18.9 SANITY GROUP GMBH 261
- 18.9.1 COMPANY SNAPSHOT 261
- 18.9.2 PRODUCT PORTFOLIO 261
- 18.9.3 RECENT DEVELOPMENT 261
18.10 PHARMA HEMP (2021) 262
- 18.10.1 COMPANY SNAPSHOT 262
- 18.10.2 PRODUCT PORTFOLIO 262
- 18.10.3 RECENT DEVELOPMENT 262
18.11 MARRICAN INC. 263
- 18.11.1 COMPANY SNAPSHOT 263
- 18.11.2 PRODUCT PORTFOLIO 263
- 18.11.3 RECENT DEVELOPMENT 263

19 QUESTIONNAIRE 264

20 RELATED REPORTS 268

LIST OF TABLES

TABLE 1 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED 72
TABLE 2 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 76
TABLE 3 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 76
TABLE 4 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 76
TABLE 5 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 77
TABLE 6 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 77
TABLE 7 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 77
TABLE 8 EUROPE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 78
TABLE 9 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 78
TABLE 10 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 79
TABLE 11 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 79
TABLE 12 EUROPE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 79
TABLE 13 EUROPE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 80
TABLE 14 EUROPE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 80
TABLE 15 EUROPE MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 82
TABLE 16 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 83
TABLE 17 EUROPE MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 85
TABLE 18 EUROPE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 88
TABLE 19 EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 92
TABLE 20 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 92
TABLE 21 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 93
TABLE 22 EUROPE ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 93
TABLE 23 EUROPE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 94
TABLE 24 EUROPE NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 94
TABLE 25 EUROPE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 95
TABLE 26 EUROPE CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 95
TABLE 27 EUROPE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 96
TABLE 28 EUROPE ALZHEIMER'S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 96
TABLE 29 EUROPE EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 97
TABLE 30 EUROPE DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 97
TABLE 31 EUROPE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 98
TABLE 32 EUROPE AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 98
TABLE 33 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 99
TABLE 34 EUROPE ELEVATE MODD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 99
TABLE 35 EUROPE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 102
TABLE 36 EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 105
TABLE 37 EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 107
TABLE 38 EUROPE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 108
TABLE 39 EUROPE MEDICAL CANNABIS MARKET, BY COUNTRY, 2022-2031 (USD MILLION) 111
TABLE 40 GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 112
TABLE 41 GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 112
TABLE 42 GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 112
TABLE 43 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 113
TABLE 44 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 113
TABLE 45 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 113
TABLE 46 GERMANY DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 113
TABLE 47 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 113
TABLE 48 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 114
TABLE 49 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 114
TABLE 50 GERMANY VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 114
TABLE 51 GERMANY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 114
TABLE 52 GERMANY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 115
TABLE 53 GERMANY MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 115
TABLE 54 GERMANY SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 115
TABLE 55 GERMANY MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 115
TABLE 56 GERMANY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 115
TABLE 57 GERMANY MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 116
TABLE 58 GERMANY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 116
TABLE 59 GERMANY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 117
TABLE 60 GERMANY ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 117
TABLE 61 GERMANY MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 118
TABLE 62 GERMANY NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 118
TABLE 63 GERMANY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 119
TABLE 64 GERMANY CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 119
TABLE 65 GERMANY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 119
TABLE 66 GERMANY ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 120
TABLE 67 GERMANY EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 120
TABLE 68 GERMANY DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 120
TABLE 69 GERMANY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 121
TABLE 70 GERMANY AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 121
TABLE 71 GERMANY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 121
TABLE 72 GERMANY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 121
TABLE 73 GERMANY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 122
TABLE 74 GERMANY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 122
TABLE 75 GERMANY MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 122
TABLE 76 GERMANY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 122
TABLE 77 GERMANY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 123
TABLE 78 U.K. MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 124
TABLE 79 U.K. MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 124
TABLE 80 U.K. MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 124
TABLE 81 U.K. OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 125
TABLE 82 U.K. OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 125
TABLE 83 U.K. OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 125
TABLE 84 U.K. DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 125
TABLE 85 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 125
TABLE 86 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 126
TABLE 87 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 126
TABLE 88 U.K. VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 126
TABLE 89 U.K. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 126
TABLE 90 U.K. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 127
TABLE 91 U.K. MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 127
TABLE 92 U.K. SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 127
TABLE 93 U.K. MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 127
TABLE 94 U.K. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 127
TABLE 95 U.K. MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 128
TABLE 96 U.K. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 128
TABLE 97 U.K. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 129
TABLE 98 U.K. ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 129
TABLE 99 U.K. MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 130
TABLE 100 U.K. NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 130
TABLE 101 U.K. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 131
TABLE 102 U.K. CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 131
TABLE 103 U.K. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 131
TABLE 104 U.K. ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 132
TABLE 105 U.K. EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 132
TABLE 106 U.K. DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 132
TABLE 107 U.K. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 133
TABLE 108 U.K. AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 133
TABLE 109 U.K. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 133
TABLE 110 U.K. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 133
TABLE 111 U.K. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 134
TABLE 112 U.K. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 134
TABLE 113 U.K. MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 134
TABLE 114 U.K. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 134
TABLE 115 U.K. B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 135
TABLE 116 ITALY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 136
TABLE 117 ITALY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 136
TABLE 118 ITALY MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 136
TABLE 119 ITALY OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 137
TABLE 120 ITALY OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 137
TABLE 121 ITALY OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 137
TABLE 122 ITALY DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 137
TABLE 123 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 137
TABLE 124 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 138
TABLE 125 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 138
TABLE 126 ITALY VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 138
TABLE 127 ITALY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 138
TABLE 128 ITALY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 139
TABLE 129 ITALY MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 139
TABLE 130 ITALY SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 139
TABLE 131 ITALY MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 139
TABLE 132 ITALY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 139
TABLE 133 ITALY MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 140
TABLE 134 ITALY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 140
TABLE 135 ITALY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 141
TABLE 136 ITALY ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 141
TABLE 137 ITALY MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 142
TABLE 138 ITALY NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 142
TABLE 139 ITALY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 143
TABLE 140 ITALY CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 143
TABLE 141 ITALY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 143
TABLE 142 ITALY ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 144
TABLE 143 ITALY EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 144
TABLE 144 ITALY DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 144
TABLE 145 ITALY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 145
TABLE 146 ITALY AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 145
TABLE 147 ITALY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 145
TABLE 148 ITALY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 145
TABLE 149 ITALY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 146
TABLE 150 ITALY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 146
TABLE 151 ITALY MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 146
TABLE 152 ITALY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 146
TABLE 153 ITALY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 147
TABLE 154 NETHERLANDS MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 148
TABLE 155 NETHERLANDS MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 148
TABLE 156 NETHERLANDS MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 148
TABLE 157 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 149
TABLE 158 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 149
TABLE 159 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 149
TABLE 160 NETHERLANDS DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 149
TABLE 161 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 149
TABLE 162 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 150
TABLE 163 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 150
TABLE 164 NETHERLANDS VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 150
TABLE 165 NETHERLANDS WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 150
TABLE 166 NETHERLANDS GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 151
TABLE 167 NETHERLANDS MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 151
TABLE 168 NETHERLANDS SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 151
TABLE 169 NETHERLANDS MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 151
TABLE 170 NETHERLANDS MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 151
TABLE 171 NETHERLANDS MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 152
TABLE 172 NETHERLANDS PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 152
TABLE 173 NETHERLANDS PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 153
TABLE 174 NETHERLANDS ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 153
TABLE 175 NETHERLANDS MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 154
TABLE 176 NETHERLANDS NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 154
TABLE 177 NETHERLANDS APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 155
TABLE 178 NETHERLANDS CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 155
TABLE 179 NETHERLANDS ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 155
TABLE 180 NETHERLANDS ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 156
TABLE 181 NETHERLANDS EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 156
TABLE 182 NETHERLANDS DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 156
TABLE 183 NETHERLANDS MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 157
TABLE 184 NETHERLANDS AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 157
TABLE 185 NETHERLANDS MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 157
TABLE 186 NETHERLANDS MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 157
TABLE 187 NETHERLANDS ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 158
TABLE 188 NETHERLANDS MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 158
TABLE 189 NETHERLANDS MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 158
TABLE 190 NETHERLANDS MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 158
TABLE 191 NETHERLANDS B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 159
TABLE 192 SWITZERLAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 160
TABLE 193 SWITZERLAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 160
TABLE 194 SWITZERLAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 160
TABLE 195 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 161
TABLE 196 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 161
TABLE 197 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 161
TABLE 198 SWITZERLAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 161
TABLE 199 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 161
TABLE 200 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 162
TABLE 201 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 162
TABLE 202 SWITZERLAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 162
TABLE 203 SWITZERLAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 162
TABLE 204 SWITZERLAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 163
TABLE 205 SWITZERLAND MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 163
TABLE 206 SWITZERLAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 163
TABLE 207 SWITZERLAND MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 163
TABLE 208 SWITZERLAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 163
TABLE 209 SWITZERLAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 164
TABLE 210 SWITZERLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 164
TABLE 211 SWITZERLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 165
TABLE 212 SWITZERLAND ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 165
TABLE 213 SWITZERLAND MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 166
TABLE 214 SWITZERLAND NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 166
TABLE 215 SWITZERLAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 167
TABLE 216 SWITZERLAND CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 167
TABLE 217 SWITZERLAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 167
TABLE 218 SWITZERLAND ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 168
TABLE 219 SWITZERLAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 168
TABLE 220 SWITZERLAND DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 168
TABLE 221 SWITZERLAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 169
TABLE 222 SWITZERLAND AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 169
TABLE 223 SWITZERLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 169
TABLE 224 SWITZERLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 169
TABLE 225 SWITZERLAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 170
TABLE 226 SWITZERLAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 170
TABLE 227 SWITZERLAND MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 170
TABLE 228 SWITZERLAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 170
TABLE 229 SWITZERLAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 171
TABLE 230 FRANCE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 172
TABLE 231 FRANCE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 172
TABLE 232 FRANCE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 173
TABLE 233 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 173
TABLE 234 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 173
TABLE 235 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 173
TABLE 236 FRANCE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 174
TABLE 237 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 174
TABLE 238 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 174
TABLE 239 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 174
TABLE 240 FRANCE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 175
TABLE 241 FRANCE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 175

TABLE 242 FRANCE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 175
TABLE 243 FRANCE MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 175
TABLE 244 FRANCE SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 175
TABLE 245 FRANCE MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 176
TABLE 246 FRANCE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 176
TABLE 247 FRANCE MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 176
TABLE 248 FRANCE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 177
TABLE 249 FRANCE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 177
TABLE 250 FRANCE ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 177
TABLE 251 FRANCE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 178
TABLE 252 FRANCE NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 178
TABLE 253 FRANCE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 179
TABLE 254 FRANCE CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 179
TABLE 255 FRANCE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 179
TABLE 256 FRANCE ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 180
TABLE 257 FRANCE EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 180
TABLE 258 FRANCE DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 180
TABLE 259 FRANCE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 181
TABLE 260 FRANCE AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 181
TABLE 261 FRANCE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 181
TABLE 262 FRANCE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 181
TABLE 263 FRANCE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 182
TABLE 264 FRANCE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 182
TABLE 265 FRANCE MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 182
TABLE 266 FRANCE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 182
TABLE 267 FRANCE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 183
TABLE 268 RUSSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 184
TABLE 269 RUSSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 184
TABLE 270 RUSSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 185
TABLE 271 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 185
TABLE 272 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 185
TABLE 273 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 185
TABLE 274 RUSSIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 186
TABLE 275 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 186
TABLE 276 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 186
TABLE 277 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 186
TABLE 278 RUSSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 187
TABLE 279 RUSSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 187
TABLE 280 RUSSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 187
TABLE 281 RUSSIA MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 187
TABLE 282 RUSSIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 187
TABLE 283 RUSSIA MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 188
TABLE 284 RUSSIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 188
TABLE 285 RUSSIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 188
TABLE 286 RUSSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 189
TABLE 287 RUSSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 189
TABLE 288 RUSSIA ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 189
TABLE 289 RUSSIA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 190
TABLE 290 RUSSIA NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 190
TABLE 291 RUSSIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 191
TABLE 292 RUSSIA CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 191
TABLE 293 RUSSIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 191
TABLE 294 RUSSIA ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 192
TABLE 295 RUSSIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 192
TABLE 296 RUSSIA DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 192
TABLE 297 RUSSIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 193
TABLE 298 RUSSIA AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 193
TABLE 299 RUSSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 193
TABLE 300 RUSSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 193
TABLE 301 RUSSIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 194
TABLE 302 RUSSIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 194
TABLE 303 RUSSIA MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 194
TABLE 304 RUSSIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 194
TABLE 305 RUSSIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 195
TABLE 306 SPAIN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 196
TABLE 307 SPAIN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 196
TABLE 308 SPAIN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 197
TABLE 309 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 197
TABLE 310 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 197
TABLE 311 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 197
TABLE 312 SPAIN DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 198
TABLE 313 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 198
TABLE 314 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 198
TABLE 315 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 198
TABLE 316 SPAIN VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 199
TABLE 317 SPAIN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 199
TABLE 318 SPAIN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 199
TABLE 319 SPAIN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 199
TABLE 320 SPAIN SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 199
TABLE 321 SPAIN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 200
TABLE 322 SPAIN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 200
TABLE 323 SPAIN MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 200
TABLE 324 SPAIN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 201
TABLE 325 SPAIN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 201
TABLE 326 SPAIN ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 201
TABLE 327 SPAIN MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 202
TABLE 328 SPAIN NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 202
TABLE 329 SPAIN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 203
TABLE 330 SPAIN CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 203
TABLE 331 SPAIN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 203
TABLE 332 SPAIN ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 204
TABLE 333 SPAIN EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 204
TABLE 334 SPAIN DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 204
TABLE 335 SPAIN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 205
TABLE 336 SPAIN AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 205
TABLE 337 SPAIN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 205
TABLE 338 SPAIN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 205
TABLE 339 SPAIN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 206
TABLE 340 SPAIN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 206
TABLE 341 SPAIN MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 206
TABLE 342 SPAIN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 206
TABLE 343 SPAIN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 207
TABLE 344 BELGIUM MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 208
TABLE 345 BELGIUM MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 208
TABLE 346 BELGIUM MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 208
TABLE 347 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 209
TABLE 348 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 209
TABLE 349 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 209
TABLE 350 BELGIUM DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 209
TABLE 351 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 209
TABLE 352 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 210
TABLE 353 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 210
TABLE 354 BELGIUM VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 210
TABLE 355 BELGIUM WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 210
TABLE 356 BELGIUM GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 211
TABLE 357 BELGIUM MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 211
TABLE 358 BELGIUM SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 211
TABLE 359 BELGIUM MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 211
TABLE 360 BELGIUM MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 211
TABLE 361 BELGIUM MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 212
TABLE 362 BELGIUM PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 212
TABLE 363 BELGIUM PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 213
TABLE 364 BELGIUM ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 213
TABLE 365 BELGIUM MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 214
TABLE 366 BELGIUM NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 214
TABLE 367 BELGIUM APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 215
TABLE 368 BELGIUM CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 215
TABLE 369 BELGIUM ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 215
TABLE 370 BELGIUM ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 216
TABLE 371 BELGIUM EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 216
TABLE 372 BELGIUM DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 216
TABLE 373 BELGIUM MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 217
TABLE 374 BELGIUM AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 217
TABLE 375 BELGIUM MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 217
TABLE 376 BELGIUM MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 217
TABLE 377 BELGIUM ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 218
TABLE 378 BELGIUM MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 218
TABLE 379 BELGIUM MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 218
TABLE 380 BELGIUM MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 218
TABLE 381 BELGIUM B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 219
TABLE 382 GREECE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 220
TABLE 383 GREECE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 220
TABLE 384 GREECE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 220
TABLE 385 GREECE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 221
TABLE 386 GREECE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 221
TABLE 387 GREECE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 221
TABLE 388 GREECE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 221
TABLE 389 GREECE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 221
TABLE 390 GREECE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 222
TABLE 391 GREECE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 222
TABLE 392 GREECE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 222
TABLE 393 GREECE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 222
TABLE 394 GREECE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 223
TABLE 395 GREECE MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 223
TABLE 396 GREECE SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 223
TABLE 397 GREECE MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 223
TABLE 398 GREECE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 223
TABLE 399 GREECE MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 224
TABLE 400 GREECE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 224
TABLE 401 GREECE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 225
TABLE 402 GREECE ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 225
TABLE 403 GREECE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 226
TABLE 404 GREECE NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 226
TABLE 405 GREECE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 227
TABLE 406 GREECE CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 227
TABLE 407 GREECE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 227
TABLE 408 GREECE ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 228
TABLE 409 GREECE EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 228
TABLE 410 GREECE DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 228
TABLE 411 GREECE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 229
TABLE 412 GREECE AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 229
TABLE 413 GREECE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 229
TABLE 414 GREECE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 229
TABLE 415 GREECE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 230
TABLE 416 GREECE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 230
TABLE 417 GREECE MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 230
TABLE 418 GREECE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 230
TABLE 419 GREECE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 231
TABLE 420 LUXEMBOURG MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 232
TABLE 421 LUXEMBOURG MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 232
TABLE 422 LUXEMBOURG MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 232
TABLE 423 LUXEMBOURG OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 233
TABLE 424 LUXEMBOURG OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 233
TABLE 425 LUXEMBOURG OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 233
TABLE 426 LUXEMBOURG DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 233
TABLE 427 LUXEMBOURG MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 233
TABLE 428 LUXEMBOURG MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2022-2031 (USD MILLION) 234
TABLE 429 LUXEMBOURG MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 234
TABLE 430 LUXEMBOURG VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 234
TABLE 431 LUXEMBOURG WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 234
TABLE 432 LUXEMBOURG GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 235
TABLE 433 LUXEMBOURG MEDICAL CANNABIS MARKET, BY SOURCE, 2022-2031 (USD MILLION) 235
TABLE 434 LUXEMBOURG SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 235
TABLE 435 LUXEMBOURG MEDICAL CANNABIS MARKET, BY SPECIES, 2022-2031 (USD MILLION) 235
TABLE 436 LUXEMBOURG MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2022-2031 (USD MILLION) 235
TABLE 437 LUXEMBOURG MEDICAL CANNABIS MARKET, BY APPLICATION, 2022-2031 (USD MILLION) 236
TABLE 438 LUXEMBOURG PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 236
TABLE 439 LUXEMBOURG PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 237
TABLE 440 LUXEMBOURG ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 237
TABLE 441 LUXEMBOURG MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 238
TABLE 442 LUXEMBOURG NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 238
TABLE 443 LUXEMBOURG APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 239
TABLE 444 LUXEMBOURG CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 239
TABLE 445 LUXEMBOURG ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 239
TABLE 446 LUXEMBOURG ALZHEIMER'S/MIGRANES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 240
TABLE 447 LUXEMBOURG EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 240
TABLE 448 LUXEMBOURG DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 240
TABLE 449 LUXEMBOURG MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 241
TABLE 450 LUXEMBOURG AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 241
TABLE 451 LUXEMBOURG MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2022-2031 (USD MILLION) 241
TABLE 452 LUXEMBOURG MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 241
TABLE 453 LUXEMBOURG ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 242
TABLE 454 LUXEMBOURG MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION) 242
TABLE 455 LUXEMBOURG MEDICAL CANNABIS MARKET, BY END USER, 2022-2031 (USD MILLION) 242
TABLE 456 LUXEMBOURG MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 242
TABLE 457 LUXEMBOURG B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION) 243
TABLE 458 REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (USD MILLION) 244
TABLE 459 REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (MILLION UNITS/MILLION MILLILITER/MILLION GRAM) 244
TABLE 460 REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2022-2031 (ASP IN UNITS, MILLILITER, GRAM) 244

LIST OF FIGURES

FIGURE 1 EUROPE MEDICAL CANNABIS MARKET: SEGMENTATION 38
FIGURE 2 EUROPE MEDICAL CANNABIS MARKET: DATA TRIANGULATION 40
FIGURE 3 EUROPE MEDICAL CANNABIS MARKET: DROC ANALYSIS 41
FIGURE 4 EUROPE MEDICAL CANNABIS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS 42
FIGURE 5 EUROPE MEDICAL CANNABIS MARKET: COMPANY RESEARCH ANALYSIS 42
FIGURE 6 EUROPE MEDICAL CANNABIS MARKET: INTERVIEW DEMOGRAPHICS 44
FIGURE 7 EUROPE MEDICAL CANNABIS MARKET: DBMR MARKET POSITION GRID 45
FIGURE 8 EUROPE MEDICAL CANNABIS MARKET: END USER COVERAGE GRID 46
FIGURE 9 EUROPE MEDICAL CANNABIS MARKET: VENDOR SHARE ANALYSIS 47
FIGURE 10 EUROPE MEDICAL CANNABIS MARKET: SEGMENTATION 51
FIGURE 11 INCREASING MEDICINAL USE AND LEGALIZATION OF THE MEDICAL CANNABIS MARKET ARE DRIVING THE GROWTH OF THE EUROPE MEDICAL CANNABIS MARKET IN THE FORECAST PERIOD OF 2024 TO 2031 52
FIGURE 12 OIL SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE MEDICAL CANNABIS MARKET IN 2024 AND 2031 52
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE MEDICAL CANNABIS MARKET 64
FIGURE 14 INCIDENCE OF EPILEPSY IN EUROPE COUNTRIES 66
FIGURE 15 EUROPE MEDICAL CANNABIS MARKET: BY PRODUCT, 2023 75
FIGURE 16 EUROPE MEDICAL CANNABIS MARKET: BY SOURCE, 2023 82
FIGURE 17 EUROPE MEDICAL CANNABIS MARKET: BY SPECIES, 2023 85
FIGURE 18 EUROPE MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2023 88
FIGURE 19 EUROPE MEDICAL CANNABIS MARKET: BY APPLICATION, 2023 91
FIGURE 20 EUROPE MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2023 101
FIGURE 21 EUROPE MEDICAL CANNABIS MARKET: BY END USER, 2023 104
FIGURE 22 EUROPE MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2023 107
FIGURE 23 EUROPE MEDICAL CANNABIS MARKET: SNAPSHOT (2023) 109
FIGURE 24 EUROPE MEDICAL CANNABIS MARKET: COMPANY SHARE 2023 (%) 245